Abordaje del implante valvular aórtico transcateter durante la pandemia por COVID-19 con alta prevoz: reporte de una serie de casos.
Palabras clave:
Aortic Valve Disease, Covid-19, Transcatheter Aortic Valve ReplacementResumen
COVID-19 pandemic generated multiple challenges for the health system. Cardiovascular disease is associated with a worse prognosis of infections. Moreover, most hospital resources and operative rooms were destined to patients with COVID-19 infection, deferring the treatment of most valvular patients requiring surgery. We report seven patients with symptomatic severe aortic stenosis who underwent transcatheter aortic valve implantation (TAVI) with conscious sedation and early discharge. No patient required intensive care unit admission or mechanical ventilation. After a 90-day follow-up, there were no complications or unplanned readmissions.Descargas
Publicado
2021-10-15
Cómo citar
Veas, N., Winter, J. L., Valdebenito, M., Honorato, F., Muñoz, R., Lidenfjeld, D., & Méndez, M. (2021). Abordaje del implante valvular aórtico transcateter durante la pandemia por COVID-19 con alta prevoz: reporte de una serie de casos. Revista Médica De Chile, 150(2). Recuperado a partir de https://revistamedicadechile.cl/index.php/rmedica/article/view/9051
Número
Sección
Artículos de Investigación